Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry.

Patricia JuliaoKeele E WurstJeanne M PimentaKim GemzoeHelain LandyM Anthony MoodyHugh TilsonDeborah CovingtonTammy MooreRebecca MarinoJennifer GilbrideAndrew LiuPaige MeizlikMichelle Petri

Published in: Birth defects research (2022)

Low recruitment numbers for the BPR and incomplete information limit the conclusions regarding belimumab exposure during pregnancy. There was no pattern or common mechanism of birth defects associated with belimumab within the BPR data.

Keyphrases

systemic lupus erythematosus
electronic health record
preterm birth
pregnancy outcomes
big data
healthcare
machine learning
pregnant women
artificial intelligence